HRP20161655T1 - Bezvodni kristalni oblik dimetoksi docetaksela i postupci za njegovu pripravu - Google Patents

Bezvodni kristalni oblik dimetoksi docetaksela i postupci za njegovu pripravu Download PDF

Info

Publication number
HRP20161655T1
HRP20161655T1 HRP20161655TT HRP20161655T HRP20161655T1 HR P20161655 T1 HRP20161655 T1 HR P20161655T1 HR P20161655T T HRP20161655T T HR P20161655TT HR P20161655 T HRP20161655 T HR P20161655T HR P20161655 T1 HRP20161655 T1 HR P20161655T1
Authority
HR
Croatia
Prior art keywords
preparation
hydroxy
procedures
crystalline form
dimethoxy
Prior art date
Application number
HRP20161655TT
Other languages
English (en)
Croatian (hr)
Inventor
Pascal Billot
Marielle Dufraigne
Hagit Elmaleh
Alexandre Guiliani
Fabrice Mangin
Patricia Rortais
Lionel Zaske
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39712334&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20161655(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of HRP20161655T1 publication Critical patent/HRP20161655T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HRP20161655TT 2008-01-17 2009-01-15 Bezvodni kristalni oblik dimetoksi docetaksela i postupci za njegovu pripravu HRP20161655T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0800243A FR2926551A1 (fr) 2008-01-17 2008-01-17 Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
PCT/FR2009/000042 WO2009115655A2 (fr) 2008-01-17 2009-01-15 Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
EP09722321.8A EP2247582B1 (fr) 2008-01-17 2009-01-15 Forme cristalline anhydre du diméthoxy docétaxel et ses procédés de préparation

Publications (1)

Publication Number Publication Date
HRP20161655T1 true HRP20161655T1 (hr) 2017-01-27

Family

ID=39712334

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20161655TT HRP20161655T1 (hr) 2008-01-17 2009-01-15 Bezvodni kristalni oblik dimetoksi docetaksela i postupci za njegovu pripravu

Country Status (42)

Country Link
US (5) US8378128B2 (pt)
EP (2) EP2247582B1 (pt)
JP (3) JP5932219B2 (pt)
KR (3) KR20150042303A (pt)
CN (3) CN101918385B (pt)
AR (1) AR070175A1 (pt)
AU (1) AU2009227081B2 (pt)
BR (1) BRPI0906518A2 (pt)
CA (1) CA2712373C (pt)
CL (1) CL2009000094A1 (pt)
CO (1) CO6351784A2 (pt)
CR (1) CR11532A (pt)
CY (1) CY1119129T1 (pt)
DK (1) DK2247582T3 (pt)
DO (3) DOP2010000211A (pt)
EA (1) EA017670B1 (pt)
EC (1) ECSP10010324A (pt)
ES (1) ES2606228T3 (pt)
FR (1) FR2926551A1 (pt)
HN (1) HN2010001435A (pt)
HR (1) HRP20161655T1 (pt)
HU (1) HUE032150T2 (pt)
IL (2) IL207031A (pt)
LT (1) LT2247582T (pt)
MA (1) MA32086B1 (pt)
ME (2) ME02694B (pt)
MX (1) MX2010007840A (pt)
MY (1) MY159362A (pt)
NI (4) NI201001031A (pt)
NZ (3) NZ598289A (pt)
PH (1) PH12013500102A1 (pt)
PL (1) PL2247582T3 (pt)
PT (1) PT2247582T (pt)
RS (1) RS55519B1 (pt)
SG (1) SG179446A1 (pt)
SI (1) SI2247582T1 (pt)
TN (1) TN2010000284A1 (pt)
TW (3) TW201444814A (pt)
UA (1) UA105896C2 (pt)
UY (1) UY31602A1 (pt)
WO (1) WO2009115655A2 (pt)
ZA (1) ZA201105206B (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102770131A (zh) 2009-10-29 2012-11-07 安万特医药股份有限公司 卡巴他赛的新颖抗肿瘤用途
JP2014514306A (ja) * 2011-04-12 2014-06-19 プラス・ケミカルス・エスアー 固体形態のカバジタキセル及びその製造方法
TWI526437B (zh) * 2011-09-09 2016-03-21 台灣神隆股份有限公司 卡巴他賽之結晶型
EP2760848B1 (en) 2011-09-26 2018-11-28 Fresenius Kabi Oncology Limited Processes for the preparation of cabazitaxel involving c(7)-oh and c(13)-oh silylation or just c(7)-oh silylation
CN102503913B (zh) * 2011-10-20 2014-03-26 江苏红豆杉生物科技股份有限公司 直接用于x射线单晶衍射分析的二甲氧基紫杉烷类化合物单晶晶体的制备方法
CN103874692A (zh) 2011-11-01 2014-06-18 费森尤斯卡比肿瘤学有限公司 卡巴他赛的无定形形式和用于其制备的方法
CN104011035A (zh) * 2011-11-28 2014-08-27 费森尤斯卡比肿瘤学有限公司 卡巴他赛的晶型和用于制备其的方法
JP6025861B2 (ja) * 2011-12-13 2016-11-16 アベンティス・ファーマ・ソシエテ・アノニム カバジタキセルの結晶形およびこれを調製するための方法
WO2013111157A1 (en) * 2012-01-03 2013-08-01 Shilpa Medicare Limited Process for preparing amorphous cabazitaxel
US9394266B2 (en) 2012-03-08 2016-07-19 IVAX International GmbH Solid state forms of cabazitaxel and processes for preparation thereof
CN102675257B (zh) * 2012-05-10 2014-07-02 上海金和生物技术有限公司 一种卡巴他赛晶体及其制备方法
CN102746258B (zh) 2012-07-25 2015-02-04 重庆泰濠制药有限公司 卡巴他赛的结晶形式及其制备方法
CN104583189A (zh) 2012-07-31 2015-04-29 永信药品工业股份有限公司 非晶型的卡巴利他索
TWI599373B (zh) 2012-08-15 2017-09-21 永信藥品工業股份有限公司 卡巴利他索（ｃａｂａｚｉｔａｘｅｌ）之穩定醫藥調配物
CN103664836B (zh) * 2012-09-20 2016-04-20 齐鲁制药有限公司 7β,10β-二甲氧基多西紫杉醇氘代丙酮合物的晶型A及其制备方法
CN102898406B (zh) * 2012-11-02 2014-12-03 上海金和生物技术有限公司 一种卡巴他赛晶体及其制备方法
CN103058960B (zh) * 2012-12-12 2014-12-10 江苏奥赛康药业股份有限公司 卡巴他赛多晶型形式及其制备方法
EP2743264A1 (en) 2012-12-13 2014-06-18 INDENA S.p.A. New crystalline form of cabazitaxel, process for the preparation and pharmaceutical compositions thereof
KR101429543B1 (ko) * 2012-12-13 2014-08-14 주식회사 삼양바이오팜 카바지탁셀의 신규 결정형 및 그 제조방법
CN103910698B (zh) * 2012-12-30 2016-01-20 上海医药工业研究院 卡巴他赛丙酮合物及其结晶
CN103910697B (zh) * 2012-12-30 2016-08-03 上海医药工业研究院 卡巴他赛乙酸合物及其结晶
CN103910696B (zh) * 2012-12-30 2016-01-20 上海医药工业研究院 卡巴他赛异丙醚合物及其结晶
AU2013368947B2 (en) * 2012-12-31 2016-11-24 Shilpa Medicare Limited Process for preparing amorphous Cabazitaxel
WO2014115168A2 (en) * 2013-01-23 2014-07-31 Leiutis Pharmaceuticals Private Limited Novel solvate forms of cabazitaxel and process for preparation thereof
WO2014128728A2 (en) * 2013-02-25 2014-08-28 Laurus Labs Private Limited Solid forms of cabazitaxel and processes for preparation thereof
EP2815749A1 (en) 2013-06-20 2014-12-24 IP Gesellschaft für Management mbH Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern
WO2015000165A1 (zh) * 2013-07-04 2015-01-08 北京新天宇科技开发有限公司 二甲氧基多西紫杉醇一丙酮化物的稳定转化物及其结晶形式、以及它们的制备方法
CN103450119B (zh) * 2013-09-24 2015-06-17 天津炜捷制药有限公司 一种卡巴他赛晶型w及其制备方法
EP2865675A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. A crystalline anhydrous form of Cabazitaxel, process for the preparation and pharmaceutical compositions thereof
EP2865674A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. Crystalline solvate forms of Cabazitaxel
CN103601704B (zh) * 2013-11-22 2015-05-06 石家庄智恒医药科技有限公司 无定形卡巴他赛的制备
CN104945453B (zh) * 2014-03-28 2018-06-26 江苏天士力帝益药业有限公司 吡唑衍生物的多晶型物
US10188626B2 (en) 2015-11-03 2019-01-29 Cipla Limited Stabilized cabazitaxel formulations
WO2020249507A1 (en) 2019-06-11 2020-12-17 Indena S.P.A. Anhydrous crystalline form of cabazitaxel, a process for its preparation and pharmaceutical compositions containing it

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2163837C (en) * 1994-12-13 1999-07-20 Robert K. Perrone Crystalline paclitaxel hydrates
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US5847170A (en) * 1995-03-27 1998-12-08 Rhone-Poulenc Rorer, S.A. Taxoids, their preparation and pharmaceutical compositions containing them
FR2745814B1 (fr) * 1996-03-06 1998-04-03 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2771092B1 (fr) 1997-11-18 1999-12-17 Rhone Poulenc Rorer Sa Procede de preparation de derives de la classe des taxoides
US6346543B1 (en) * 1998-08-17 2002-02-12 Aventis Pharma S.A. Use of a taxoid to treat abnormal cell proliferation in the brain
AU2002365883A1 (en) * 2001-11-30 2003-06-17 Bristol-Myers Squibb Company Paclitaxel solvates
FR2859996B1 (fr) * 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
BRPI0606132A2 (pt) * 2005-10-12 2009-06-02 Sicor Inc formas cristalinas de docetaxel e processos para seu preparo
TWI394765B (zh) * 2008-12-12 2013-05-01 Ind Tech Res Inst 難燃水性聚胺基甲酸酯分散液
CN102770131A (zh) 2009-10-29 2012-11-07 安万特医药股份有限公司 卡巴他赛的新颖抗肿瘤用途
TWI526437B (zh) 2011-09-09 2016-03-21 台灣神隆股份有限公司 卡巴他賽之結晶型
CN104011035A (zh) 2011-11-28 2014-08-27 费森尤斯卡比肿瘤学有限公司 卡巴他赛的晶型和用于制备其的方法
JP6025861B2 (ja) 2011-12-13 2016-11-16 アベンティス・ファーマ・ソシエテ・アノニム カバジタキセルの結晶形およびこれを調製するための方法

Also Published As

Publication number Publication date
ME02694B (me) 2017-10-20
EP2247582B1 (fr) 2016-09-07
CA2712373C (fr) 2016-06-14
CN101918385A (zh) 2010-12-15
PH12013500102A1 (en) 2015-09-16
US20130178639A1 (en) 2013-07-11
MA32086B1 (fr) 2011-02-01
NZ598289A (en) 2013-06-28
JP5932219B2 (ja) 2016-06-08
TW201444813A (zh) 2014-12-01
MX2010007840A (es) 2010-08-04
CY1119129T1 (el) 2018-02-14
DOP2010000211A (es) 2010-07-31
CA2712373A1 (fr) 2009-09-24
HK1150603A1 (en) 2012-01-06
LT2247582T (lt) 2017-01-25
US8846959B2 (en) 2014-09-30
ZA201105206B (en) 2013-05-29
KR20150042303A (ko) 2015-04-20
NI201001033A (es) 2011-04-26
MY159362A (en) 2016-12-30
JP2011509980A (ja) 2011-03-31
JP2014074054A (ja) 2014-04-24
US20190144406A1 (en) 2019-05-16
EP2719694A1 (fr) 2014-04-16
BRPI0906518A2 (pt) 2015-07-14
SG179446A1 (en) 2012-04-27
UA105896C2 (uk) 2014-07-10
KR20150042302A (ko) 2015-04-20
DK2247582T3 (da) 2017-01-02
ECSP10010324A (es) 2010-08-31
NZ603797A (en) 2013-05-31
US20140350272A1 (en) 2014-11-27
CN104130221A (zh) 2014-11-05
IL207031A0 (en) 2010-12-30
AR070175A1 (es) 2010-03-17
CR11532A (es) 2010-11-22
US8378128B2 (en) 2013-02-19
WO2009115655A2 (fr) 2009-09-24
TWI477492B (zh) 2015-03-21
CN101918385B (zh) 2014-07-02
TW201444814A (zh) 2014-12-01
CN104130220A (zh) 2014-11-05
IL229239A0 (en) 2013-12-31
AU2009227081B2 (en) 2013-11-14
AU2009227081A1 (en) 2009-09-24
CL2009000094A1 (es) 2010-02-12
US20180002302A1 (en) 2018-01-04
IL207031A (en) 2017-11-30
NI201000103A (es) 2011-04-26
PT2247582T (pt) 2016-11-16
RS55519B1 (sr) 2017-05-31
CO6351784A2 (es) 2011-12-20
SI2247582T1 (sl) 2017-03-31
UY31602A1 (es) 2009-08-31
EA201070856A1 (ru) 2011-02-28
WO2009115655A3 (fr) 2010-04-01
DOP2013000212A (es) 2014-01-31
ES2606228T3 (es) 2017-03-23
ME01009B (me) 2012-10-20
TN2010000284A1 (fr) 2011-11-11
US20110144362A1 (en) 2011-06-16
PL2247582T3 (pl) 2017-04-28
KR20100103614A (ko) 2010-09-27
HUE032150T2 (en) 2017-08-28
NZ586829A (en) 2012-05-25
TW200944510A (en) 2009-11-01
NI201001032A (es) 2011-04-26
US10160739B2 (en) 2018-12-25
DOP2013000016A (es) 2013-06-15
EA017670B1 (ru) 2013-02-28
NI201001031A (es) 2011-04-26
EP2247582A2 (fr) 2010-11-10
HN2010001435A (es) 2014-02-03
FR2926551A1 (fr) 2009-07-24
JP2015163626A (ja) 2015-09-10

Similar Documents

Publication Publication Date Title
HRP20161655T1 (hr) Bezvodni kristalni oblik dimetoksi docetaksela i postupci za njegovu pripravu
CO6630087A2 (es) Anticuerpos bivalentes biespecificos anti-vegf/anti-ang-2
AR076269A1 (es) Composicion endulzante que comprende una forma de rebaudiosida a de alta solubilidad y metodo para su produccion
RU2016129184A (ru) Жидкая композиция для электронных сигарет
EA201592055A1 (ru) 11-гидроксилпроизводные желчных кислот и их аминокислотные конъюгаты в качестве модуляторов фарнезоидных х-рецепторов
HN2011001810A (es) Sintesis de espirikpiridinas radiomarcadas con 18f a partir de precursores de tosilato y composiciones farmaceuticas estables de estas.
RU2011146462A (ru) Дымообразующая композиция для электронных устройств, имитирующих табакокурение, способ ее получения и применения
ATE547099T1 (de) Flüssige zusammensetzungen aus calciumacetat
ECSP11011278A (es) Composición farmacéutica que comprende derivados de glucopiranosil difenilmetano, forma farmacéutica de la misma, procedimiento para su preparación y usos de la misma para el control glucémico mejorado en un paciente.
DK3159329T3 (da) Anvendelse af 2-hidroxyderivater af polyumættede fedtsyrer som medikamenter
BR112012031095A2 (pt) método para preparação de uma composição de asiaticoside altamente pura a partir de centella asiatica de um método para seu uso
MX2015016543A (es) Derivados de biarilo como agonistas de gpr120.
EA201792530A1 (ru) Пероральная композиция целекоксиба для лечения боли
ECSP13012575A (es) Monohidrato de derivados de aza-adamantano
DE102009012161B8 (de) Verfahren zur Herstellung von Polysaccharidderivaten
WO2015019193A3 (en) Acylated derivatives of phloridzin and isoquercetrin as anticancer therapeutics and methods of use thereof
EA200900732A1 (ru) Кристаллическая калиевая соль аналогов липоксина а
MX384907B (es) Modulación del amargor y sensación bucal a través de mezclas sinérgicas de ácidos grasos de cadena larga.
CO2017005203A2 (es) Acido benzoico, derivados de acido benzoico y conjugados de acido carboxilico de heteroarilo de oximorfona, profarmacos, metodos de fabricacion y uso de los mismos
EP2195036A4 (en) COMPOSITIONS FOR THE TREATMENT OF TUMORS BY DIRECT ADMINISTRATION OF A RADIO ISOTOPE
EA201100525A1 (ru) Применение ацилциклогександионкарбоновой кислоты или ее солей в комбинации со сложными эфирами ацилциклогександионкарбоновой кислоты для улучшения роста злаковых растений
GEP20186827B (en) Process for synthesis of ulipristal acetate and its 4'-acetyl analogue
EP3466940A4 (en) CRYSTAL SHAPE OF SODIUM-GLUCOSE-COTRANSPORTERS-2-INHIBITOR
MY172049A (en) Frozen noodles and production method therefor
BR112017005759A2 (pt) composição de preparação externa que contém s-flurbiprofeno